In the present study, we examined the presence and persistence of the neutralizing activity of IgG fractions from 43 COVID-19-convalescent cases, quantitative and temporal correlations among the neutralizing activity and SARS-CoV-2-S1-binding antibody amounts in plasma samples and patients’ clinical severities and hospitalization lengths. The gene discussed is PSMD1; the disease is COVID-19.